跳至主要内容
临床试验/NCT00149266
NCT00149266终止3 期

Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)

Japan Clinical Oncology Group2 个研究点 分布在 1 个国家目标入组 167 人开始时间: 1995年7月1日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
167
试验地点
2
主要终点
overall survival

研究概览

简要总结

To compare left thoraco-abdominal approach with abdominal and transhiatal approach to cardia or subcardia cancer

详细描述

For gastric cancers with esophageal invasion (Siewert type II and III), thoraco-abdominal approach has shown better survival results than abdominal approach in retrospective analyses. However, patients having mediastinal nodal metastasis have poor prognosis and the benefit of thoraco-abdominal approach is still controversial. We evaluated the two approaches in a prospective randomized trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically proven adenocarcinoma
  • 75 years old or younger
  • forced expiratory volume in one second ≥ 50 %
  • arterial oxygen pressure in room air ≥ 70 mmHg
  • clinically T2/T3/T4 with ≤3 cm esophageal invasion
  • written consent

排除标准

  • Carcinoma in the remnant stomach
  • Borrmann type 4 (linitis plastica)
  • synchronous or metachronous malignancy in other organs except for cervical carcinoma in situ and colorectal focal cancer in adenoma
  • history of left thoracotomy, or left pleural adhesion
  • past history of myocardial infarction or positive results of exercise ECG
  • liver cirrhosis, or chronic liver disease with indocyanine green test ≥15%

结局指标

主要结局

overall survival

次要结局

  • relapse-free survival
  • operative morbidity and mortality
  • quality of life

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验